{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:23:26Z","timestamp":1789539806895,"version":"build-2803163510"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Deanship of Research and Graduate Studies at King Khalid University","award":["Large Research Project grant (RGP2\/639\/46)"],"award-info":[{"award-number":["Large Research Project grant (RGP2\/639\/46)"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adverse drug reactions (ADRs) are associated with hospitalization, increased healthcare cost, morbidity and mortality. This study aimed to investigate the prevalence, severity and associated factors of ADRs among patients taking antipsychotics at Mbarara Regional Referral Hospital (MRRH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted among patients taking antipsychotics at the psychiatric clinic from March to May 2025. Consecutive sampling was employed whereby all eligible patients attending the psychiatric clinic during the study period were recruited until the required sample size was attained. All patients aged 18 years and above, diagnosed with a psychotic disorder, and who had received an antipsychotic for at least the previous one month were interviewed. STATA version 17 was used for statistical data analysis. Descriptive statistics were presented as mean and standard deviation or median and interquartile ranges. ADRs were analyzed for severity using the modified Hartwig and Siegel scale. We run multivariable logistic regression analysis to determine factors associated with ADRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 415 participants were included in the study with a mean age of 38. Fifteen ADRs were commonly reported among patients taking antipsychotics. More than half of the participants (256\/415, 61.70%) experienced at least one ADR, with sedation being the most frequent (31.3%). Of the reported ADRs, 12\/15 (80%) were moderate in severity. Separation from spouses (AOR\u2009=\u20092.01, 95% CI [1.08\u20133.77],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.029), diagnosed with bipolar disorder (AOR\u2009=\u20092.09, 95% CI [1.07\u20134.07],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031), and co-administering both IM &amp; oral antipsychotic (AOR\u2009=\u20091.95, 95% CI [1.03\u20133.70],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.041) were significantly associated with ADRs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The current study showed that over 6 in 10 participants taking antipsychotics experienced at least one ADR, the majority of which were moderate in severity. Separation from a spouse, bipolar disorder, concomitant use of oral and intramascular antipsychotics were independently associated with ADRs. These findings highlight the need for strengthen monitoring and preventive strategies, particularly among high-risk patients taking antipsychotics. Integration of clinical pharmacists into the psychiatry care teams may further enhance ADR detection, monitoring and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0356000","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:36:46Z","timestamp":1786642606000},"page":"e0356000","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence, severity and predictors of Antipsychotic-Related Adverse Drug Reactions at the Psychiatry Clinic of a Regional Referral Hospital in Uganda"],"prefix":"10.1371","volume":"21","author":[{"given":"John Martin","family":"Tumwebaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarad Pawar Naik","family":"Bukke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7084-2014","authenticated-orcid":true,"given":"Bayapa Reddy","family":"Narapureddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radiana Makuza","family":"Kabera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Sebisaalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick Muasya","family":"Kitheka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godwin","family":"Nimusiima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9286-877X","authenticated-orcid":true,"given":"Awad Osman Abdalla","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Muwanguzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scholastic","family":"Ashaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-2610","authenticated-orcid":true,"given":"Tadele Mekuriya","family":"Yadesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"pone.0356000.ref001","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Fifth Edition Text Revision DSM-5-TRTM. 2022."},{"issue":"12","key":"pone.0356000.ref002","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019","volume":"28","author":"M Solmi","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"8","key":"pone.0356000.ref003","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2215-0366(21)00009-2","article-title":"The epidemiology of psychiatric disorders in Africa: a scoping review","volume":"8","author":"MC Greene","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"pone.0356000.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218843","article-title":"One year prevalence of psychotic disorders among first treatment contact patients at the National Psychiatric Referral and Teaching Hospital in Uganda","volume":"15","author":"EK Mwesiga","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"pone.0356000.ref005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/acps.13669","article-title":"Antipsychotic agents in anxiety disorders: An umbrella review","volume":"149","author":"A Garakani","year":"2024","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"pone.0356000.ref006","first-page":"183","article-title":"A systematic review of the real-world effectiveness and economic and humanistic outcomes of selected oral antipsychotics among patients with schizophrenia in the United States: Updating the evidence and gaps","volume":"30","author":"KJ Jeun","year":"2024","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"pone.0356000.ref007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/wps.21205","article-title":"Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts","volume":"23","author":"H Taipale","year":"2024","journal-title":"World Psychiatry"},{"key":"pone.0356000.ref008","volume-title":"Basic & clinical pharmacology","author":"BG Katzung","year":"2018","edition":"14"},{"issue":"3","key":"pone.0356000.ref009","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3390\/healthcare12030339","article-title":"Third-generation antipsychotics and lurasidone in the treatment of substance-induced psychoses: a narrative review","volume":"12","author":"V Ricci","year":"2024","journal-title":"Healthcare (Basel)"},{"key":"pone.0356000.ref010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/NDT.S455279","article-title":"New therapeutic targets and drugs for schizophrenia beyond dopamine d2 receptor antagonists","volume":"20","author":"A Peng","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"key":"pone.0356000.ref011","unstructured":"World Health Organization. Safety of Medicines: A guide to detecting and reporting adverse drug reactions. https:\/\/iris.who.int\/bitstream\/handle\/10665\/67378\/WHO_EDM_QSM_2002.2.pdf?sequence=1. 2002."},{"issue":"2","key":"pone.0356000.ref012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13651501.2017.1381268","article-title":"Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study","volume":"22","author":"N Desai","year":"2018","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"1","key":"pone.0356000.ref013","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12246","article-title":"Prevalence of and risk factors for extrapyramidal side effects of antipsychotics: results from the national FACE-SZ cohort","volume":"80","author":"D Misdrahi","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"pone.0356000.ref014","article-title":"Antipsychotic-induced extrapyramidal side effects: a systematic review and meta-analysis of observational studies","volume":"16","author":"T Ali","year":"2021","journal-title":"PLoS One"},{"key":"pone.0356000.ref015","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2147\/CIA.S332251","article-title":"Prevalence, incidence, and characteristics of adverse drug reactions among older adults hospitalized at Mbarara Regional Referral Hospital, Uganda: a prospective cohort study","volume":"16","author":"TM Yadesa","year":"2021","journal-title":"Clinical Interventions in Aging"},{"issue":"9","key":"pone.0356000.ref016","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1176\/appi.ajp.2017.16091016","article-title":"The long-term effects of antipsychotic medication on clinical course in schizophrenia","volume":"174","author":"DC Goff","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"9","key":"pone.0356000.ref017","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1177\/02698811221104055","article-title":"Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019","volume":"36","author":"S Oh","year":"2022","journal-title":"J Psychopharmacol"},{"issue":"3","key":"pone.0356000.ref018","first-page":"144","article-title":"Prevalence and severity of adverse drug reactions among patients receiving antipsychotic drugs in a tertiary care hospital","volume":"10","author":"NB Angadi","year":"2020","journal-title":"International Journal of Nutrition, Pharmacology, Neurological Diseases"},{"key":"pone.0356000.ref019","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.2147\/NDT.S349127","article-title":"Adverse drug reaction and its predictors among psychiatric patients taking psychotropic medications at the mizan-tepi university teaching hospital","volume":"17","author":"F Ejeta","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"pone.0356000.ref020","article-title":"A Prospective observational study to evaluate the prevalence of adverse drug reactions and its impact on quality of life in psychiatric patients at a tertiary care teaching hospital","volume":"16","author":"M Patel","year":"2023","journal-title":"Medical Journal of Dr DY Patil Vidyapeeth"},{"issue":"1","key":"pone.0356000.ref021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/aip.aip_148_22","article-title":"Assessment of adverse drug reactions identified in the outpatient department of psychiatry","volume":"7","author":"J Dsouza","year":"2023","journal-title":"Annals of Indian Psychiatry"},{"issue":"3","key":"pone.0356000.ref022","doi-asserted-by":"crossref","first-page":"341","DOI":"10.5455\/2319-2003.ijbcp20130623","article-title":"Adverse drug reaction profile at psychiatry out-patient department of a tertiary referral centre in Central India","volume":"2","author":"B Solanke","year":"2013","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"10","key":"pone.0356000.ref023","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/14740338.2021.1938539","article-title":"Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: a retrospective review of hospital admissions due to adverse drug reactions","volume":"20","author":"R Li","year":"2021","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"pone.0356000.ref024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13561-024-00481-y","article-title":"Evaluating the costs of adverse drug events in hospitalized patients: a systematic review","volume":"14","author":"M Durand","year":"2024","journal-title":"Health Econ Rev"},{"issue":"7","key":"pone.0356000.ref025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055551","article-title":"Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions","volume":"12","author":"R Osanlou","year":"2022","journal-title":"BMJ Open"},{"issue":"6","key":"pone.0356000.ref026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/02537176241233745","article-title":"Types of medication non-adherence & approaches to enhance medication adherence in mental health disorders: a narrative review","volume":"46","author":"A Jayasree","year":"2024","journal-title":"Indian J Psychol Med"},{"key":"pone.0356000.ref027","first-page":"165","article-title":"Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: comparing the top four reporting countries (US, UK, Canada and Australia)","volume":"268","author":"C De Las Cuevas","year":"2024","journal-title":"Schizophr Res"},{"issue":"11","key":"pone.0356000.ref028","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1111\/bcp.14851","article-title":"Fatal adverse drug reactions: a worldwide perspective in the World Health Organization pharmacovigilance database","volume":"87","author":"J-L Montastruc","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0356000.ref029","unstructured":"Center for Drug Evaluation and Research. Preventable Adverse Drug Reactions: A Focus on Drug Interactions. https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/preventable-adverse-drug-reactions-focus-drug-interactions. 2021. Accessed 2024 May 1."},{"issue":"1","key":"pone.0356000.ref030","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12872-022-02937-7","article-title":"Prevalence and factors associated with adverse drug reactions among heart failure patients hospitalized at Mbarara Regional Referral Hospital, Uganda","volume":"22","author":"EA Shegena","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"pone.0356000.ref031","unstructured":"Leslie K. Survey Sampling - Leslie Kish - Google Books. 1965 [cited 2024 Nov 13]. https:\/\/books.google.co.ug\/books\/about\/Survey_Sampling.html?id=xiZmAAAAIAAJ&redir_esc=y"},{"issue":"1","key":"pone.0356000.ref032","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5530\/ijpcs.5.1.3","article-title":"Prevalence and Severity of Adverse Drug Reactions (ADRs) in patients subjected to different Anti-psychotic drugs in an Out-Patient Department of a Psychiatry Hospital in Kashmir; a prospective observational study","volume":"5","author":"A Ahmad","year":"2016","journal-title":"IJPCS"},{"issue":"2","key":"pone.0356000.ref033","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S1092852921000456","article-title":"Long-acting injectable antipsychotics: what, when, and how - Addendum","volume":"26","author":"L Citrome","year":"2021","journal-title":"CNS Spectr"},{"key":"pone.0356000.ref034","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1207\/s15327752jpa5201_2","article-title":"The multidimensional scale of perceived social support","volume":"52","author":"G Zimet","year":"1988","journal-title":"J PERSONAL ASSESS"},{"issue":"2","key":"pone.0356000.ref035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"CA Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"pone.0356000.ref036","first-page":"2229","article-title":"Preventability and severity assessment in reporting adverse drug reactions","volume":"49","author":"SC Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"issue":"6","key":"pone.0356000.ref037","first-page":"538","article-title":"Focusing on the preventability of adverse drug reactions","volume":"27","author":"GT Schumock","year":"1992","journal-title":"Hosp Pharm"},{"issue":"1","key":"pone.0356000.ref038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"DE Morisky","year":"1986","journal-title":"Med Care"},{"issue":"1","key":"pone.0356000.ref039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12888-018-1999-x","article-title":"Prevalence and management practice of first generation antipsychotics induced side effects among schizophrenic patients at Amanuel Mental Specialized Hospital, central Ethiopia: cross-sectional study","volume":"19","author":"YS Wubeshet","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"3","key":"pone.0356000.ref040","doi-asserted-by":"crossref","DOI":"10.5001\/omj.2024.75","article-title":"Adverse drug reactions among hospitalized psychiatric patients, prevalence, severity, preventability, and opportunities for intervention","volume":"39","author":"A Al Hindi","year":"2024","journal-title":"Oman Med J"},{"issue":"2","key":"pone.0356000.ref041","article-title":"Adverse drug reactions due to atypical antipsychotics in the absence of other centrally acting drugs among patients with mental illness","volume":"10","author":"V Subeesh","year":"2019","journal-title":"Archives of Pharmacy Practice"},{"key":"pone.0356000.ref042","article-title":"Antipsychotic drug utilization and adverse drug reaction profiling in patients with schizophrenia at a tertiary care hospital in Western India","volume":"14","author":"RK Tripathi","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"pone.0356000.ref043","doi-asserted-by":"crossref","first-page":"09","DOI":"10.25176\/RFMH.v24i1.6060","article-title":"Analysis of Adverse Drug Reactions caused by antipsychotic drugs in a Mexican health institute","volume":"24","author":"E Rojas-Valladares","year":"2024","journal-title":"RFMH"},{"key":"pone.0356000.ref044","article-title":"Factors affecting medication adherence among patient with schizophrenia: A literature review","author":"F Rohmi","year":"2022","journal-title":"medRxiv"},{"issue":"6","key":"pone.0356000.ref045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/cap.2019.0123","article-title":"Frequency and correlates of acute dystonic reactions after antipsychotic initiation in 441 children and adolescents","volume":"30","author":"S Tural Hesapcioglu","year":"2020","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"pone.0356000.ref046","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/2279-042X.137063","article-title":"Identification and management of adverse effects of antipsychotics in a tertiary care teaching hospital","volume":"3","author":"JM Lucca","year":"2014","journal-title":"J Res Pharm Pract"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0358548","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:36:53Z","timestamp":1786642613000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356000"}},"subtitle":[],"editor":[{"given":"Joseph Olusesan","family":"Fadare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356000","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}